Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program.

Chiarelli AM, Blackmore KM, Muradali D, Done SJ, Majpruz V, Weerasinghe A, Mirea L, Eisen A, Rabeneck L, Warner E.

J Natl Cancer Inst. 2019 Jun 24. pii: djz079. doi: 10.1093/jnci/djz079. [Epub ahead of print]

PMID:
31233143
2.

Annual versus biennial screening: diagnostic accuracy among concurrent cohorts within the Ontario Breast Screening Program.

Chiarelli AM, Blackmore KM, Mirea L, Done SJ, Majpruz V, Weerasinghe A, Rabeneck L, Muradali D.

J Natl Cancer Inst. 2019 Jun 24. pii: djz131. doi: 10.1093/jnci/djz131. [Epub ahead of print]

PMID:
31233138
3.

Implementing smoking cessation within cancer treatment centres and potential economic impacts.

Evans WK, Truscott R, Cameron E, Rana S, Isaranuwatchai W, Haque M, Rabeneck L.

Transl Lung Cancer Res. 2019 May;8(Suppl 1):S11-S20. doi: 10.21037/tlcr.2019.05.09.

4.

The Global Paradigm Shift in Screening for Colorectal Cancer.

Young GP, Rabeneck L, Winawer SJ.

Gastroenterology. 2019 Mar;156(4):843-851.e2. doi: 10.1053/j.gastro.2019.02.006. Epub 2019 Feb 16. No abstract available.

PMID:
30776340
5.

Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.

Llovet D, Serenity M, Conn LG, Bravo CA, McCurdy BR, Dubé C, Baxter NN, Paszat L, Rabeneck L, Peters A, Tinmouth J.

Am J Gastroenterol. 2018 Dec;113(12):1872-1880. doi: 10.1038/s41395-018-0381-4. Epub 2018 Oct 25.

6.

A framework to build capacity for a reflex-testing program for Lynch syndrome.

Palter VN, Baker NA, Rabeneck L, Tinmouth J, Gagliardi AR, Kennedy ED, Carroll JC, Gallinger S, Baxter NN.

Genet Med. 2019 Jun;21(6):1381-1389. doi: 10.1038/s41436-018-0342-8. Epub 2018 Oct 22.

PMID:
30349099
7.

Risk of Invasive Cervical Cancer Among Immigrants in Ontario, Canada.

Aston O, Sutradhar R, Rabeneck L, Paszat L.

J Obstet Gynaecol Can. 2019 Jan;41(1):21-28. doi: 10.1016/j.jogc.2018.01.031. Epub 2018 Oct 10.

8.

Learning by Example: An International Perspective on Reflex-Testing for Lynch Syndrome.

Palter VN, Baker NA, Pollett A, Daly C, Facey M, Rotenberg C, Rabeneck L, Baxter NN.

Ann Surg Oncol. 2019 Feb;26(2):425-436. doi: 10.1245/s10434-018-6809-7. Epub 2018 Oct 1.

PMID:
30276639
9.

Validation of 5 key colonoscopy-related data elements from Ontario health administrative databases compared to the clinical record: a cross-sectional study.

Tinmouth J, Sutradhar R, Liu N, Baxter NN, Paszat L, Rabeneck L.

CMAJ Open. 2018 Aug 13;6(3):E330-E338. doi: 10.9778/cmajo.20180013. Print 2018 Jul-Sep.

10.

The IARC Perspective on Colorectal Cancer Screening.

Pinsky P, Rabeneck L, Lauby-Secretan B.

N Engl J Med. 2018 Jul 19;379(3):301-302. doi: 10.1056/NEJMc1807173. No abstract available.

PMID:
30021099
11.

Economic evaluation of smoking cessation in Ontario's regional cancer programs.

Djalalov S, Masucci L, Isaranuwatchai W, Evans W, Peter A, Truscott R, Cameron E, Mittmann N, Rabeneck L, Chan K, Hoch JS.

Cancer Med. 2018 Sep;7(9):4765-4772. doi: 10.1002/cam4.1495. Epub 2018 Jul 17.

12.

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S.

Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.

13.

Reply.

Bielawska B, Hookey LC, Whitehead M, Paszat LF, Rabeneck L, Tinmouth J.

Gastroenterology. 2018 Jun;154(8):2279-2280. doi: 10.1053/j.gastro.2018.05.018. Epub 2018 May 8. No abstract available.

PMID:
29750910
14.

Consolidated principles for screening based on a systematic review and consensus process.

Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L.

CMAJ. 2018 Apr 9;190(14):E422-E429. doi: 10.1503/cmaj.171154.

15.

Predictors of non-adherence to colorectal cancer screening among immigrants to Ontario, Canada: a population-based study.

Shen SC, Lofters A, Tinmouth J, Paszat L, Rabeneck L, Glazier RH.

Prev Med. 2018 Jun;111:180-189. doi: 10.1016/j.ypmed.2018.03.002. Epub 2018 Mar 13.

PMID:
29548788
16.

Seven-day postcolonoscopy emergency department visits: What do they really measure?

Dubé C, Rabeneck L.

Gastrointest Endosc. 2018 Feb;87(2):526-528. doi: 10.1016/j.gie.2017.10.023. No abstract available.

PMID:
29406932
17.

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Eisen A, Blackmore KM, Meschino WS, Muradali D, Carroll JC, Majpruz V, Warner E, Rabeneck L, Chiarelli AM.

Mol Genet Genomic Med. 2018 Mar;6(2):213-223. doi: 10.1002/mgg3.359. Epub 2018 Jan 25.

18.

Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals.

Sutradhar R, Asidianya N, Lee F, Coburn N, Rabeneck L, Paszat L.

Gastric Cancer. 2018 Jul;21(4):588-597. doi: 10.1007/s10120-017-0790-x. Epub 2017 Dec 28.

PMID:
29285629
19.

Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial.

Ayub K, Ketwaroo G, Abudayyeh S, Ibrahim A, Cole RA, Brumfield-Brown R, Qureshi WA, Rabeneck L, Graham DY.

J Dig Dis. 2017 Dec;18(12):691-697. doi: 10.1111/1751-2980.12562.

PMID:
29160622
20.

Repeat Colonoscopy within 6 Months after Initial Outpatient Colonoscopy in Ontario: A Population-Based Cross-Sectional Study.

Paszat L, Sutradhar R, Baxter NN, Tinmouth J, Rabeneck L.

Can J Gastroenterol Hepatol. 2017;2017:5917057. doi: 10.1155/2017/5917057. Epub 2017 Sep 7.

21.

Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method.

Catomeris P, Baxter NN, Boss SC, Paszat LF, Rabeneck L, Randell E, Serenity ML, Sutradhar R, Tinmouth J.

Arch Pathol Lab Med. 2018 Jan;142(1):75-82. doi: 10.5858/arpa.2016-0294-OA. Epub 2017 Oct 2.

PMID:
28967803
22.

BETTER HEALTH: Durham -- protocol for a cluster randomized trial of BETTER in community and public health settings.

Paszat L, Sutradhar R, O'Brien MA, Lofters A, Pinto A, Selby P, Baxter N, Donnelly PD, Elliott R, Glazier RH, Kyle R, Manca D, Pietrusiak MA, Rabeneck L, Sopcak N, Tinmouth J, Wall B, Grunfeld E.

BMC Public Health. 2017 Sep 29;17(1):754. doi: 10.1186/s12889-017-4797-3.

23.

Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy.

Murthy SK, Dubé C, Rostom A, Benchimol EI, Ducharme R, Sutradhar R, Rabeneck L, Paszat L, Tinmouth J.

Endoscopy. 2017 Dec;49(12):1229-1236. doi: 10.1055/s-0043-117402. Epub 2017 Sep 15.

PMID:
28915524
24.

Anesthesia Assistance in Outpatient Colonoscopy and Risk of Aspiration Pneumonia, Bowel Perforation, and Splenic Injury.

Bielawska B, Hookey LC, Sutradhar R, Whitehead M, Xu J, Paszat LF, Rabeneck L, Tinmouth J.

Gastroenterology. 2018 Jan;154(1):77-85.e3. doi: 10.1053/j.gastro.2017.08.043. Epub 2017 Sep 1.

PMID:
28865733
25.

Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study.

James PD, Rabeneck L, Yun L, Paszat L, Baxter NN, Govindarajan A, Antonova L, Tinmouth JM.

J Med Screen. 2018 Sep;25(3):141-148. doi: 10.1177/0969141317718860. Epub 2017 Sep 1.

PMID:
28862521
26.

In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis.

Thorell K, Bengtsson-Palme J, Liu OH, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, Sjöling Å.

Infect Immun. 2017 Sep 20;85(10). pii: e00031-17. doi: 10.1128/IAI.00031-17. Print 2017 Oct.

27.

Risk of colorectal cancer among immigrants to Ontario, Canada.

Paszat L, Sutradhar R, Liu Y, Baxter NN, Tinmouth J, Rabeneck L.

BMC Gastroenterol. 2017 Jul 6;17(1):85. doi: 10.1186/s12876-017-0642-5.

28.

Corrigendum: Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening?

Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L.

Am J Gastroenterol. 2017 Jun;112(6):974. doi: 10.1038/ajg.2017.119. Epub 2017 Apr 18.

PMID:
28417995
29.

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.

Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I.

PLoS One. 2017 Mar 15;12(3):e0172864. doi: 10.1371/journal.pone.0172864. eCollection 2017.

30.

A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive result on a fecal occult blood test in Ontario's ColonCancerCheck program.

Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J.

Curr Oncol. 2017 Feb;24(1):47-51. doi: 10.3747/co.24.3025. Epub 2017 Feb 27.

31.

Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening?

Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L.

Am J Gastroenterol. 2017 Apr;112(4):622-632. doi: 10.1038/ajg.2017.4. Epub 2017 Feb 28. Erratum in: Am J Gastroenterol. 2017 Jun;112(6):974.

PMID:
28244494
32.

Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials.

Ritvo P, Myers RE, Serenity M, Gupta S, Inadomi JM, Green BB, Jerant A, Tinmouth J, Paszat L, Pirbaglou M, Rabeneck L.

Prev Med. 2017 Aug;101:229-234. doi: 10.1016/j.ypmed.2016.12.024. Epub 2016 Dec 24.

PMID:
28024865
33.

How to Make Feedback More Effective? Qualitative Findings from Pilot Testing of an Audit and Feedback Report for Endoscopists.

Webster F, Patel J, Rice K, Baxter N, Paszat L, Rabeneck L, Tinmouth J.

Can J Gastroenterol Hepatol. 2016;2016:4983790. Epub 2016 Sep 18.

34.

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

Bombard Y, Rozmovits L, Sorvari A, Daly C, Carroll JC, Kennedy E, Rabeneck L, Baxter NN.

Genet Med. 2017 May;19(5):568-574. doi: 10.1038/gim.2016.150. Epub 2016 Oct 6.

PMID:
27711070
35.

The Quality of Colonoscopy Reporting in Usual Practice: Are Endoscopists Reporting Key Data Elements?

Hadlock SD, Liu N, Bernstein M, Gould M, Rabeneck L, Ruco A, Sutradhar R, Tinmouth JM.

Can J Gastroenterol Hepatol. 2016;2016:1929361. doi: 10.1155/2016/1929361. Epub 2016 Aug 7.

36.

Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.

Paszat L, Sutradhar R, Tinmouth J, Baxter N, Rabeneck L.

Can J Gastroenterol Hepatol. 2016;2016:4768728. doi: 10.1155/2016/4768728. Epub 2016 May 8.

37.

Training non-physicians to do endoscopy: Feasibility, effectiveness and cost-effectiveness.

Ruco A, Walsh CM, Cooper MA, Rabeneck L.

Best Pract Res Clin Gastroenterol. 2016 Jun;30(3):389-96. doi: 10.1016/j.bpg.2016.04.006. Epub 2016 May 4. Review.

PMID:
27345647
38.

Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening.

Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):907-17. doi: 10.1158/1055-9965.EPI-15-0990. Epub 2016 Apr 13. Review.

39.

Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua.

Thorell K, Hosseini S, Palacios Gonzáles RV, Chaotham C, Graham DY, Paszat L, Rabeneck L, Lundin SB, Nookaew I, Sjöling Å.

BMC Evol Biol. 2016 Feb 29;16:53. doi: 10.1186/s12862-016-0619-y.

40.

Colorectal Cancer.

Rabeneck L, Horton S, Zauber AG, Earle C.

In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 6.

41.

Small-area variation in screening for cancer, glucose and cholesterol in Ontario: a cross-sectional study.

Fernandes KA, Sutradhar R, Borkhoff CM, Baxter N, Lofters A, Rabeneck L, Tinmouth J, Paszat L; Ontario Cancer Screening Research Network.

CMAJ Open. 2015 Oct 29;3(4):E373-81. doi: 10.9778/cmajo.20140069. eCollection 2015 Oct-Dec.

42.

Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865. Epub 2016 Feb 1.

43.

Colorectal cancer mortality reduction is associated with having at least 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age.

Stock D, Paszat LF, Rabeneck L.

Gastrointest Endosc. 2016 Jul;84(1):133-41. doi: 10.1016/j.gie.2015.12.035. Epub 2016 Jan 6.

PMID:
26769406
44.

Assessment of a cancer screening program.

Rabeneck L, Lansdorp-Vogelaar I.

Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):979-85. doi: 10.1016/j.bpg.2015.09.009. Epub 2015 Sep 11. Review.

PMID:
26651258
45.

Evaluation of a clinical risk index for advanced colorectal neoplasia among a North American population of screening age.

Ruco A, Stock D, Hilsden RJ, McGregor SE, Paszat LF, Saskin R, Rabeneck L.

BMC Gastroenterol. 2015 Nov 19;15:162. doi: 10.1186/s12876-015-0395-y.

46.

Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.

Gelband H, Sankaranarayanan R, Gauvreau CL, Horton S, Anderson BO, Bray F, Cleary J, Dare AJ, Denny L, Gospodarowicz MK, Gupta S, Howard SC, Jaffray DA, Knaul F, Levin C, Rabeneck L, Rajaraman P, Sullivan T, Trimble EL, Jha P; Disease Control Priorities-3 Cancer Author Group.

Lancet. 2016 May 21;387(10033):2133-2144. doi: 10.1016/S0140-6736(15)00755-2. Epub 2015 Nov 11. Review.

PMID:
26578033
47.

Repeat colonoscopy after a colonoscopy with a negative result in Ontario: a population-based cohort study.

Hol L, Sutradhar R, Gu S, Baxter NN, Rabeneck L, Tinmouth JM, Paszat LF; investigators of the Ontario Cancer Screening Research Network.

CMAJ Open. 2015 Apr 2;3(2):E244-50. doi: 10.9778/cmajo.20140063. eCollection 2015 Apr-Jun.

48.

Hospitalization Rates Among Survivors of Young Adult Malignancies.

Richardson DP, Daly C, Sutradhar R, Paszat LF, Wilton AS, Rabeneck L, Baxter NN.

J Clin Oncol. 2015 Aug 20;33(24):2655-9. doi: 10.1200/JCO.2014.60.1914. Epub 2015 Jul 13.

PMID:
26169617
49.

Colorectal cancer screening: a global overview of existing programmes.

Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ.

Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3. Review.

PMID:
26041752
50.

Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.

Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J.

Prev Med. 2015 Jul;76:115-22. doi: 10.1016/j.ypmed.2015.03.028. Epub 2015 Apr 18.

PMID:
25895843

Supplemental Content

Loading ...
Support Center